Loading cancer entity…
Loading cancer entity…
Clinical trials
68 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03950609 | Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors | active not recruiting | Phase 2 | 36 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT05037461 | Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients(PRIME) | active not recruiting | N/A | 20 | J.M. de LaatOTHER | 1 | Sep 9, 2026 | clinicaltrials |
| NCT03655223 | Early Check: Expanded Screening in Newborns | active not recruiting | — | 30,000 | RTI InternationalOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT03048279 | Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2 | active not recruiting | — | 1,500 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT04175678 | Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men | active not recruiting | N/A | 100 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterOTHER | 1 | Mar 10, 2026 | clinicaltrials |
Data updated 11 days agoSource updated Sep 18, 2026source: clinicaltrials